Effects of Budesonide and Fluticasone Propionate in Pediatric Asthma Patients

Pediatrics and Neonatology

Volumn 51, Issue 1, 2010, Pages 31-36

  Kuo, Lin Yu ^a   Hung, Chih Hsing ^a,b,c   Tseng, Hsing I ^a   Wu, Jiunn Ren ^a,d   Jong, Yuh Jyh ^a,b,c   Chu, Yu Te ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Department of Otorhinolaryngology Head and Neck Surgery   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

asthma; budesonide; chemokine; cytokine; exhaled NO; fluticasone

Indexed keywords

BUDESONIDE; CORTICOSTEROID; FLIXOTIDE ACCUHALER; FLUTICASONE PROPIONATE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; NITRIC OXIDE; OBUCORT SWINGHALER; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DRUG RESPONSE; FEMALE; HUMAN; LUNG FUNCTION; MALE; PEAK EXPIRATORY FLOW; PROTEIN BLOOD LEVEL;

ADOLESCENT; ANDROSTADIENES; ASTHMA; BREATH TESTS; BUDESONIDE; CHEMOKINE CCL17; CHEMOKINE CXCL10; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LUNG; MALE; NITRIC OXIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76749124058     PISSN: 18759572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1875-9572(10)60007-1     Document Type: Article

References (26)

1. Barnes P.J., Chung K.F., and Page C.P. Inflammatory mediators of asthma: an update. Pharmacol Rev 50 (1998) 515-596
2. Thomas P.S. Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma. Immunol Cell Biol 79 (2001) 132-140
3. Kips J.C. Cytokines in asthma. Eur Respir J Suppl 34 (2001) 24s-33s
4. Bochner B.S., Hudson S.A., Xiao H.Q., and Liu M.C. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions. J Allergy Clin Immunol 112 (2003) 930-934
5. Liu L., Jarjour N.N., Busse W.W., and Kelly E.A. Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma. Am J Respir Crit Care Med 169 (2004) 1118-1124
6. Hung C.H., Li C.Y., Lai Y.S., Hsu P.C., Hua Y.M., and Yang K.D. Discrepant clinical responses and blood chemokine profiles between two non-steroidal anti-inflammatory medications for children with mild persistent asthma. Pediatr Allergy Immunol 16 (2005) 306-309
7. Leung T.F., Wong C.K., Lam C.W.K., et al. Plasma TARC concentration may be a useful marker for asthmatic exacerbation in children. Eur Respir J 21 (2003) 616-620
8. Imai T., Baba M., Nishimura M., Kakizaki M., Takagi S., and Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 272 (1997) 15036-15042
9. Liu A.H., Zeiger R., Sorkness C., et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 119 (2007) 817-825
10. Schatz M., Sorkness C.A., Li J.T., et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 117 (2006) 549-556
11. Global Initiative for Asthma. Global strategy for asthma management and prevention. In: National Institutes of Health. National Heart, Lung, and Blood Institute, 2008. Available at: http://www.ginasthma.com/ [Date accessed: December 20, 2008]
12. Juniper E.F., Kline P.A., Vanzieleghem M.A., Ramsdale E.H., O'Byrne P.M., and Hargreave F.E. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 142 (1990) 832-836
13. National Institutes of Health. Expert panel report 3: guidelines for the diagnosis and management of asthma. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf [Date accessed: December 20, 2008]
14. Khor Y.H., Feltis B.N., Reid D.W., et al. Airway cell and cytokine changes in early asthma deterioration after inhaled corticosteroid reduction. Clin Exp Allergy 37 (2007) 1189-1198
15. Nathan R.A., Sorkness C.A., Kosinski M., et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 113 (2004) 59-65
16. Burke C., Power C.K., Norris A., Condez A., Schmekel B., and Poulter L.W. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. Eur Respir J 5 (1992) 73-79
17. Burke C.M., Sreenan S., Power C.K., Pathmakanthan S., and Poulter L.W. Mechanism of action of inhaled corticosteroids in bronchial asthma: a controlled study. Eur Respir J 7 (1994) 421S [Abstract]
18. Barnes P.J. Molecular mechanisms of glucocorticoid action in asthma. Pulm Pharmacol Ther 10 (1997) 3-19
19. Rizzo M.C., and Sole D. Inhaled corticosteroids in the treatment of respiratory allergy: safety vs. efficacy. J Pediatr (Rio J) 82 (2006) S198-S205
20. Panina-Bordignon P., Papi A., Mariani M., et al. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest 107 (2001) 1357-1364
21. Lai S.T., Hung C.H., Hua Y.M., Hsu S.H., Jong Y.J., and Suen J.L. T-helper 1-related chemokines in the exacerbation of childhood asthma. Pediatr Int 50 (2008) 99-102
22. Kips J.C., Tavernier J.H., Joos G.F., Peleman R.A., and Pauwels R.A. The potential role of tumour necrosis factor alpha in asthma. Clin Exp Allergy 23 (1993) 247-250
23. Kharitonov S.A., and Barnes P.J. Exhaled biomarkers. Chest 130 (2006) 1541-1546
24. Pijnenburg M.W., and De Jongste J.C. Exhaled nitric oxide in childhood asthma: a review. Clin Exp Allergy 38 (2008) 246-259
25. Adams N., Lasserson T.J., Cates C.J., and Jones P.W. Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children. Cochrane Database Syst Rev (2007) CD002310.
26. Yang J.Z., Young A.L., Chiang P.C., Thurston A., and Pretzer D.K. Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies. J Pharm Sci 97 (2008) 4869-4878